BioCentury | Mar 9, 2020
Finance

GenFleet eyes proof of concept with $50M series B

...has served as SVP of operations at CStone Pharmaceuticals Co. Ltd. (HKEX:2616) and CSO at Harbin Gloria Pharmaceuticals Co. Ltd....
BioCentury | Dec 7, 2018
Financial News

After Ally Bridge-backed series A, Shanghai's GenFleet looks to clinic

...operations at CStone Pharmaceuticals Co. Ltd. (Suzhou, China), and before that CSO and VP of Harbin Gloria Pharmaceuticals Co. Ltd....
BioCentury | Dec 6, 2018
Financial News

After Ally Bridge-backed series A, Shanghai's GenFleet looks to clinic

...operations at CStone Pharmaceuticals Co. Ltd. (Suzhou, China), and before that CSO and VP of Harbin Gloria Pharmaceuticals Co. Ltd....
BioCentury | Aug 31, 2018
Financial News

Harbin Gloria selling stake in biotech unit to new investors

...Harbin Gloria Pharmaceuticals Co. Ltd. (SZSE:002437) said Aug. 17 it plans to sell a 51% stake in...
...Harbin Gloria gained RMB0.39 to RMB4.59 on Aug. 17. Harbin Gloria Pharmaceuticals Co. Ltd. (SZSE:002437), Harbin, China Mary Romeo GLS-010, WBP3055 Harbin Gloria Pharmaceuticals Co. Ltd....
BioCentury | Aug 17, 2018
Financial News

Harbin Gloria selling stake in biotech unit

...Harbin Gloria Pharmaceuticals Co. Ltd. (SZSE:002437) said Friday it plans to sell a 51% stake in biotech...
...Bridge Invests in Tasly Pharmaceuticals" ). Harbin Gloria gained RMB0.39 to RMB4.59 on Friday. Mary Romeo GLS-010, WBP3055 Harbin Gloria Pharmaceuticals Co. Ltd. Programmed...
BioCentury | May 11, 2018
Clinical News

Arcus reports Phase I safety data for cancer candidate AB928

...rights in North America, Europe, Japan and undisclosed other regions from WuXi Biologics Inc. (HKSE:2269). Harbin Gloria Pharmaceuticals Co. Ltd....
...mid-2018); start Phase I/Ib (mid-2018); Phase I/Ib data (1H19) Sandi Wong AB122 AB928 American Association for Cancer Research Arcus Biosciences Inc. Harbin Gloria Pharmaceuticals Co. Ltd. WuXi...
BioCentury | Mar 16, 2018
Financial News

Arcus raises upsized $120M IPO

...rights in North America, Europe, Japan and undisclosed other regions from WuXi Biologics Inc. (HKSE:2269). Harbin Gloria Pharmaceuticals Co. Ltd....
BioCentury | Mar 15, 2018
Financial News

Modest first-day pop for Arcus after upsized $120M IPO

...rights in North America, Europe, Japan and undisclosed other regions from WuXi Biologics Inc. (HKSE:2269). Harbin Gloria Pharmaceuticals Co. Ltd....
BioCentury | Nov 17, 2017
Financial News

Immuno-oncology play Arcus raises $107M

...in North America, Europe, Japan and other undisclosed regions from WuXi Biologics Inc. (HKSE:2269) and Harbin Gloria Pharmaceuticals Co. Ltd....
BioCentury | Nov 14, 2017
Financial News

Immuno-oncology play Arcus raises $107M

...in North America, Europe, Japan and other undisclosed regions from WuXi Biologics Inc. (HKSE:2269) and Harbin Gloria Pharmaceuticals Co. Ltd....
Items per page:
1 - 10 of 19
BioCentury | Mar 9, 2020
Finance

GenFleet eyes proof of concept with $50M series B

...has served as SVP of operations at CStone Pharmaceuticals Co. Ltd. (HKEX:2616) and CSO at Harbin Gloria Pharmaceuticals Co. Ltd....
BioCentury | Dec 7, 2018
Financial News

After Ally Bridge-backed series A, Shanghai's GenFleet looks to clinic

...operations at CStone Pharmaceuticals Co. Ltd. (Suzhou, China), and before that CSO and VP of Harbin Gloria Pharmaceuticals Co. Ltd....
BioCentury | Dec 6, 2018
Financial News

After Ally Bridge-backed series A, Shanghai's GenFleet looks to clinic

...operations at CStone Pharmaceuticals Co. Ltd. (Suzhou, China), and before that CSO and VP of Harbin Gloria Pharmaceuticals Co. Ltd....
BioCentury | Aug 31, 2018
Financial News

Harbin Gloria selling stake in biotech unit to new investors

...Harbin Gloria Pharmaceuticals Co. Ltd. (SZSE:002437) said Aug. 17 it plans to sell a 51% stake in...
...Harbin Gloria gained RMB0.39 to RMB4.59 on Aug. 17. Harbin Gloria Pharmaceuticals Co. Ltd. (SZSE:002437), Harbin, China Mary Romeo GLS-010, WBP3055 Harbin Gloria Pharmaceuticals Co. Ltd....
BioCentury | Aug 17, 2018
Financial News

Harbin Gloria selling stake in biotech unit

...Harbin Gloria Pharmaceuticals Co. Ltd. (SZSE:002437) said Friday it plans to sell a 51% stake in biotech...
...Bridge Invests in Tasly Pharmaceuticals" ). Harbin Gloria gained RMB0.39 to RMB4.59 on Friday. Mary Romeo GLS-010, WBP3055 Harbin Gloria Pharmaceuticals Co. Ltd. Programmed...
BioCentury | May 11, 2018
Clinical News

Arcus reports Phase I safety data for cancer candidate AB928

...rights in North America, Europe, Japan and undisclosed other regions from WuXi Biologics Inc. (HKSE:2269). Harbin Gloria Pharmaceuticals Co. Ltd....
...mid-2018); start Phase I/Ib (mid-2018); Phase I/Ib data (1H19) Sandi Wong AB122 AB928 American Association for Cancer Research Arcus Biosciences Inc. Harbin Gloria Pharmaceuticals Co. Ltd. WuXi...
BioCentury | Mar 16, 2018
Financial News

Arcus raises upsized $120M IPO

...rights in North America, Europe, Japan and undisclosed other regions from WuXi Biologics Inc. (HKSE:2269). Harbin Gloria Pharmaceuticals Co. Ltd....
BioCentury | Mar 15, 2018
Financial News

Modest first-day pop for Arcus after upsized $120M IPO

...rights in North America, Europe, Japan and undisclosed other regions from WuXi Biologics Inc. (HKSE:2269). Harbin Gloria Pharmaceuticals Co. Ltd....
BioCentury | Nov 17, 2017
Financial News

Immuno-oncology play Arcus raises $107M

...in North America, Europe, Japan and other undisclosed regions from WuXi Biologics Inc. (HKSE:2269) and Harbin Gloria Pharmaceuticals Co. Ltd....
BioCentury | Nov 14, 2017
Financial News

Immuno-oncology play Arcus raises $107M

...in North America, Europe, Japan and other undisclosed regions from WuXi Biologics Inc. (HKSE:2269) and Harbin Gloria Pharmaceuticals Co. Ltd....
Items per page:
1 - 10 of 19